We are live on ! Find out more
ONCY

Oncolytics Biotech
ONCY

22 hedge funds and large institutions have $360K invested in Oncolytics Biotech in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

26% more capital invested

Capital invested by funds: $284K → $360K (+$75.4K)

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

5% more funds holding

Funds holding: 21 → 22 (+1)

0.11% more ownership

Funds ownership: 0.93% → 1.03% (+0.11%)

Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$59.8K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$14.8K
3
Deutsche Bank
Deutsche Bank
Germany
+$14.3K
4
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$1.67K
5
SC
Scotia Capital
Ontario, Canada
+$448

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$10.3K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$8.96K
3
Bank of America
Bank of America
North Carolina
-$436
4
UBS Group
UBS Group
Switzerland
-$243
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$89K -$10.3K -5,100 -10%
SC
2
Scotia Capital
Ontario, Canada
$82K +$448 +221 +0.5%
Citadel Advisors
3
Citadel Advisors
Florida
$54K +$59.8K +29,520 New
Comerica Bank
4
Comerica Bank
Texas
$29K – – –
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$28K +$14.8K +7,324 +93%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$19K -$8.96K -4,424 -30%
Deutsche Bank
7
Deutsche Bank
Germany
$15K +$14.3K +7,050 +542%
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Quebec, Canada
$14.6K – – –
Bank of Montreal
9
Bank of Montreal
Ontario, Canada
$11K +$213 +105 +2%
NFG
10
Next Financial Group
Texas
$4K – – –
NFH
11
NEXT Financial Holdings
Texas
$4K +$3.84K +1,893 New
LTFS
12
Ladenburg Thalmann Financial Services
Florida
$3K – – –
HNB
13
Huntington National Bank
Ohio
$2K – – –
Toronto Dominion Bank
14
Toronto Dominion Bank
Ontario, Canada
$2K +$1.67K +822 +391%
Bank of America
15
Bank of America
North Carolina
$1K -$436 -215 -32%
UBS Group
16
UBS Group
Switzerland
$1K -$243 -120 -15%
Wells Fargo
17
Wells Fargo
California
$1K – – –
APA
18
American Portfolios Advisors
New York
$195 – – –

ONCY Hedge Fund Activity: Q1 2019 in Review

22 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q1 2019, worth a combined $360K — up 26% from $284K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ONCY positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $59.8K. The largest seller was Morgan Stanley, cutting an estimated $10.3K.

  • 22 institutional investors held Oncolytics Biotech (ONCY) as of Q1 2019, up from 21 in Q4 2018.
  • Funds reported $360K of Oncolytics Biotech stock for Q1 2019, up 26% quarter-over-quarter.
  • 2 funds opened new Oncolytics Biotech positions in Q1 2019 and 1 closed out, a net change of +1 holder.
  • The largest Oncolytics Biotech buyer in Q1 2019 was Citadel Advisors, an estimated $59.8K added.
  • The largest Oncolytics Biotech seller in Q1 2019 was Morgan Stanley, an estimated $10.3K sold.

Based on aggregated 13F filings for Q1 2019.